Core Insights - MEDIROM Healthcare Technologies Inc. reported an increase in total customers served and sales per customer for November 2024, indicating positive business growth [2][3] - The company maintains a stable repeat customer ratio, reflecting customer loyalty [2][3] Salon Operation Business - Total customers served rose to 75,760 in November 2024 from 75,290 in November 2023, marking an increase of 0.62% [2][3] - Sales per customer increased to JPY 7,055 in November 2024 from JPY 7,045 in the same month last year, a slight increase of 0.14% [2][3] - The repeat customer ratio remained unchanged at 77.5% year-over-year [2][3] - The operation ratio improved to 44.6% in November 2024 from 43.9% in the previous year [2][3] Number of Salons - As of November 2024, the company operated 308 salons, a slight decrease from 311 in January 2024 [3][21] - The number of salons with available data was 283 in November 2024 [3] Health Tech Business (Lav®) - The company has entered into contracts with 95 corporate insurance associations, with a cumulative user base exceeding 8,515 individuals for its Lav® app as of November 2024 [16][21] - The health guidance program aims to assist individuals at risk of lifestyle-related diseases through remote support [8][15] Market Context - The Japanese government has set targets for specific medical checkup and health guidance implementation rates, which are currently below the desired levels, indicating potential market expansion opportunities for healthcare services [9]

Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and Growth Potential.Further Commercialization with Recent 25,000 Unit Order from B2B Sales Channel. TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. raised to date an aggregate total of 260.3 million yen (approximtaely USD $ [1.7] million calculated ...

Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and Growth Potential.Further Commercialization with Recent 25,000 Unit Order from B2B Sales Channel. TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. raised to date an aggregate total of 260.3 million yen (approximtaely USD $ [1.7] million calculated ...

TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), “MEDIROM”, a holistic healthcare company that operates over 300 wellness salons across Japan and provides healthcare services, today announced the closing of its public offering of 2,860,000 American Depositary Shares at a public offering price of $1.75 per share, for gross proceeds of approximately $5,000,000 before deducting underwriting discounts and offering expenses. In addition, MEDIROM has granted the underwr ...

TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that two senior executives, Issei Homan, Chief Technology Officer of MEDIROM MOTHER Labs Inc. (“Mother Labs”), a subsidiary of MEDIROM, and Yasuhiro Hayami, Chief Business Officer of Mother Labs, invested in Mother Labs’ Series A financing at a pre-money valuation of of JPY9 billion (as of December 1, 2024, approximately USD $59,000,000). Messrs. Homan and Hayami are committed s ...

Company Overview - MEDIROM Healthcare Technologies Inc. is involved in health-tech and has announced participation from M3, Inc. in its Series A equity financing round for its subsidiary, MEDIROM MOTHER Labs Inc. [1] - The Series A financing round is led by NFES Technologies Inc. with a pre-money valuation of JPY 9 billion [1] MOTHER Labs and Product Offering - MEDIROM MOTHER Labs focuses on health-tech, offering the "Specific Health Guidance Program" through the "Lav" health application and developing the 24/7 recharge-free MOTHER Bracelet smart tracker [5] - The MOTHER Bracelet is notable for being the world's first 24/7 recharge-free smart tracker, utilizing innovative technology to generate power from temperature differences [7] - The device records five basic health metrics: heart rate, calories burned, body surface temperature, step count, and sleep [7] M3, Inc. Background - M3, Inc. operates a global physician platform and is recognized for its significant member panel, which includes over 330,000 Japanese and more than 6.5 million global physicians [4]

TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. ...

TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on Nasdaq, NASDAQ: MRM; hereinafter "MEDIROM") announces that its subsidiary MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; CEO: Yoshio Uekusa; hereinafter "MOTHER Labs"), has formed a capital and business alliance with NFES Technologies Inc. (Headquarters: Matsue City, Shimane Prefecture; CEO: Keita Adachi; hereinafter "NFES Group"), a subsidiary of NFES Inc. (H ...

TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ("we", "our", "us" or "the Company") hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase a rehabilitation business from Y's, Inc., a Japanese corporation, as of July 10, 2024. Y`s, Inc. operates 10 rehabilitation facilities around Tokyo for survivors of cerebral infarction, a type of stroke, and the company does business with major private, public and university hospitals in Japa ...

TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ("we", "our", "us" or "the Company") hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase a rehabilitation business from Y's, Inc., a Japanese corporation, as of July 10, 2024. Y`s, Inc. operates 10 rehabilitation facilities around Tokyo for survivors of cerebral infarction, a type of stroke, and the company does business with major private, public and university hospitals in Japa ...